TCTR20170526002招募中4 期
Efficacy and safety of bimatoprost in vitiligo: A randomized single-blinded controlled study
Department of dermatology, Siriraj Hospital0 个研究点目标入组 25 人开始时间: 2017年5月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Stable nonsegmental and segmental vitiligo lesions (for the last 3 months)
- •2. Without received any local treatment for vitiligo for at least 2 weeks before the study
- •3. Without received any photo therapy for vitiligo for at least 4 weeks before the study
排除标准
- •1. Photosensitive patients, those with light aggravated dermatoses
- •2. Pregnant
- •3. Lactating females and patients with asthma or hypertension
研究者
相似试验
撤回
4 期
Topical Bimatoprost Solution 0.03%in Stable VitiligoVitiligoRepigmentationNCT01202513Gian Sagar Medical College and Hospital20
尚未招募
4 期
Research study to evaluate safety and effectiveness of preservative free bimatoprost 0.01% ophthalmic solution in comparison to conventional bimatoprost 0.01%) ophthalmic solution in glaucoma or ocular hypertension patients in Indian populatioCTRI/2019/04/018738Sun Pharma Laboratories Ltd
已完成
3 期
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash ProminenceEyelashesNCT00693420Allergan278
已完成
不适用
Comparison of therapeutic effects of minocycline versus light therapy in vitiligo treatmentIRCT2013122315246N2Isfahan Medical University42
已完成
2 期
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic AlopeciaAlopecia, AndrogeneticBaldnessAlopeciaNCT01325337Allergan307